key: cord-0894783-bbar8u4h
authors: Yang, Jie; D’Souza, Rohan; Kharrat, Ashraf; Fell, Deshayne B.; Snelgrove, John W.; Murphy, Kellie E.; Shah, Prakesh S.
title: Coronavirus disease 2019 pandemic and pregnancy and neonatal outcomes in general population: A living systematic review and meta‐analysis (updated Aug 14, 2021)
date: 2021-11-03
journal: Acta Obstet Gynecol Scand
DOI: 10.1111/aogs.14277
sha: 785cd9daa4deb957ce2d3331c8e268e8a97e4e0f
doc_id: 894783
cord_uid: bbar8u4h

INTRODUCTION: Conflicting reports of increases and decreases in rates of preterm birth (PTB) and stillbirth in the general population during the coronavirus disease 2019 (COVID‐19) pandemic have surfaced. The objective of our study was to conduct a living systematic review and meta‐analyses of studies reporting pregnancy and neonatal outcomes by comparing the pandemic and pre‐pandemic periods. MATERIAL AND METHODS: We searched PubMed and Embase databases, reference lists of articles published up until August 14, 2021 and included English language studies that compared outcomes between the COVID‐19 pandemic time period and the pre‐pandemic time periods. Risk of bias was assessed using the Newcastle–Ottawa scale. We conducted random‐effects meta‐analysis using the inverse variance method. RESULTS: Forty‐five studies with low‐to‐moderate risk of bias, reporting on 1 843 665 pregnancies during the pandemic period and 23 564 552 pregnancies during the pre‐pandemic period, were included. There was significant reduction in unadjusted estimates of PTB (35 studies, unadjusted odds ratio [uaOR] 0.95, 95% CI 0.92–0.98), but not in adjusted estimates (six studies, adjusted OR [aOR] 0.95, 95% CI 0.80–1.13). This reduction was noted in studies from single centers/health areas (25 studies, uaOR 0.90, 95% CI 0.86–0.96) but not in regional/national studies (10 studies, uaOR 0.99, 95% CI 0.95–1.02). There was reduction in spontaneous PTB (six studies, uaOR 0.89, 95% CI 0.81–0.96) and induced PTB (five studies, uaOR 0.89, 95% CI 0.81–0.97). There was no difference in the odds of stillbirth between the pandemic and pre‐pandemic time periods (24 studies, uaOR 1.11, 95% CI 0.97–1.26 and four studies, aOR 1.06, 95% CI 0.81–1.38). There was an increase in mean birthweight during the pandemic period compared with the pre‐pandemic period (six studies, mean difference 17 g, 95% CI 7–28 g). The odds of maternal mortality were increased (four studies, uaOR 1.15, 95% CI 1.05–1.26); however, only unadjusted estimates were available and the result was mostly influenced by one study from Mexico. There was significant publication bias for the outcome of PTB. CONCLUSIONS: The COVID‐19 pandemic may be associated with a reduction in PTB; however, referral bias cannot be excluded. There was no statistically significant difference in stillbirth between pandemic and pre‐pandemic periods.

Most pregnancies end with healthy mothers and healthy children, but a small proportion result in adverse outcomes for the mother, fetus, or neonate. Among others, such outcomes include stillbirth, preterm birth (PTB), neonatal mortality, and maternal mortality-all of which can have devastating and long-lasting effects on families. 1-3 Preterm birth (birth before 37 weeks of gestation) is a major determinant of neonatal mortality and morbidity 4 with long-term adverse consequences during childhood and adulthood. 5 Medical, social, psychological, environmental, and economic factors have all been implicated in the etiopathogenesis of PTB and other adverse pregnancy outcomes.

The coronavirus disease 2019 (COVID-19) pandemic has had an unprecedented impact on society worldwide and provided a natural experiment allowing us to study the effects of these factors on adverse pregnancy outcomes. During the early stages of the pandemic, reports emerged describing reduced PTB rates in Denmark 6 and Ireland. 7 However, these were followed by reports of increased PTB rates (births between 28 and 32 weeks of gestation) in Nepal 8 and no changes in PTB rates in the UK 9 and Sweden. 10 At the same time, increases in stillbirth rates were reported from the UK 9 and Nepal, 8 with or without changes in PTB rates, whereas no change in the stillbirth rate was reported from Ireland. 2 In light of these mixed reports, it is uncertain whether or not the COVID-19 pandemic has affected pregnancy outcomes at the population level. Inconsistency among conclusions from different studies and a lack of evidence to inform the creation of evidence-based population health guidance prompted us to undertake a comprehensive review of the influence of the COVID-19 pandemic on pregnancy outcomes.

Our objective was to systematically review and meta-analyze studies reporting defined local, regional, or national population-based rates for maternal, fetal, and neonatal outcomes during the pandemic period compared with the pre-pandemic period.

The review was conducted using standardized methods for systematic reviews of observational studies and reported according to the Preferred Reporting Items in Systematic Reviews and Meta-analyses guidelines. 11 No ethical approval was obtained because all data used for these analyses were published previously. The review protocol was registered in PROSPERO (CRD42021234036). 12 This is update #1 of a previously published review. 13

This is update #1 for this living systematic review and metaanalyses. The search was updated to August 14, 2021 . Nine new eligible studies were identified, and their data were incorporated into this new analysis. An additional nine potentially eligible studies were identified; however, they are currently in abstract or pre-print format, so are not included in this update. One study, which was included in our previous version, is now excluded because of the availability of data from a larger cohort from the same region. The findings in this update are consistent with our previous version: the odds of PTB during the pandemic were significantly reduced in unadjusted estimates and in single-center/single-healthauthority studies, but there was no difference in odds of PTB in studies using regional/national data. There was no difference in the odds of stillbirth between the pandemic and non-pandemic periods. There still exists the possibility of publication bias for outcome of preterm birth.

MeSH terms "preterm" or "stillbirth" AND "Covid19" or "SARS-CoV-2" and included any type of study design published in the English language (Appendix S1). As this is a living systematic review, it will be updated 3-monthly for the duration of the pandemic, using the same search strategy. Studies were included if they compared pregnancy outcomes between the COVID-19 pandemic period and pre-pandemic time periods and reported on any of the outcomes of interest. We excluded studies that only reported outcomes of pregnant women with COVID-19. Screening of articles was conducted by two authors (PS and JY) and disagreements were resolved through discussion (JY, RD and PS) and

consensus. As we were interested in overall pregnancy outcomes, we did not restrict studies based on plurality (including both singleton and multiple pregnancies).

In most studies, the pandemic period was defined as the period beginning from the date or month of the implementation of emergency lockdown measures in relevant countries or states or cities, or when there was an emergence of cases or a surge of cases in the population studied. Some studies assessed "post-lockdown" period which for the purpose of this study was included as "pandemic" period as we are still not out of the pandemic yet. The pre-pandemic period was defined either as the period ending immediately before lockdown measures were implemented or before the emergence of the first case or high case numbers in the population, or as a historical period, such as births in the same population in previous year(s). The lengths of these periods varied across studies.

We included studies that reported outcomes of pregnancy in general population. The review was not designed to evaluate outcomes of pregnancies where only women affected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection were reported.

The primary outcomes in this study were rates of PTB and stillbirth.

Secondary outcomes included mean birthweight (continuous) and rates of low birthweight (LBW), spontaneous PTB, medically indicated PTB, and neonatal, perinatal, or maternal mortality. We contacted authors to obtain data on stillbirth and neonatal mortality when the outcomes were reported as "intrauterine fetal death" and "perinatal mortality". The outcomes of intrauterine fetal death and perinatal mortality, though specified in the protocol, were not included ultimately in the review (deviation from protocol). Outcomes were defined as follows:

1. Preterm birth: Live births between 22 +0 and 36 +6 weeks of gestation were classified as PTB. Data on PTB at <28 weeks, <32 weeks, and <34 weeks of gestation were reported separately in some studies and were analyzed independently.

2. Stillbirth: Death before the complete expulsion or extraction from the parturient of a product of human conception at or after 20 weeks of gestation. 14 3. Birthweight: Infant weight in grams, measured as soon as possible after live birth. Birthweight <2500 g was defined as LBW, birthweight <1500 g was defined as very low birthweight (VLBW), and birthweight <1000 gram was defined as extremely low birthweight (ELBW). 

Data from the eligible studies were independently extracted by two authors (JY and PS) using a predefined, standardized extraction form. Disagreements between the authors were resolved by consensus and involving a third author (RD). The information extracted included details of the publication, study setting and size, prepandemic period definition, pandemic period definition, and rates of the reported outcomes in pre-pandemic and pandemic time periods.

We relied only on published information.

We anticipated that primarily observational studies would be included in this review, so we used the Newcastle-Ottawa Scale 15 for cohort studies to assess risk of bias. This scale assesses risk of bias in the domains of selection, comparability, and outcomes, and assigns a maximum score of 9. Studies with scores of 0 to 3 were considered to have high risk of bias, those with scores of 4 to 6 had moderate risk of bias, and those with scores of 7 to 9 had low risk of bias.

We planned for meta-analyses of studies that reported similar outcomes and were methodologically homogeneous. For binary outcomes, we calculated the summary unadjusted odds ratios (uaOR), adjusted OR (aOR) when available and 95% CI, whereas for birthweight we calculated the mean difference and 95% CI. Statistical heterogeneity was assessed using Cochran's Q statistic and quantified by calculating the I 2 values. We expected clinical and methodological heterogeneity between studies, so planned a priori for random effect meta-analyses using the inverse variance method. We planned to meta-analyze adjusted estimates from studies that reported them, understanding that studies will have adjusted for different factors based on data availability and baseline differences. We also expected that the duration of the "pre-pandemic" period would vary across studies, so we conducted meta-regression on the variable "duration of the pre-pandemic period" as a covariate to explain any heterogeneity in the results. Post-hoc subgroup analyses were conducted for the two primary outcomes after dividing studies into single-center (or selected hospitals/centers in an area), regional (statewide or province-wide) or national in scope. Publication bias was assessed qualitatively, using funnel plots, and quantitatively, by calculating Egger's regression intercept when more than 10 studies were included in the meta-analyses. For the Egger test, values less than 0.10 were considered indicative of publication bias. Meta-analyses were conducted using STATA v11.0 (StataCorp, College Station, TX, USA)

and Review ManageR v5.3 (Cochrane Collaboration).

Of 9953 records in the initial search, 45 articles were eligible for inclusion, of which 44 were used in the quantitative synthesis 2,6-10,16-53 ( Figure 1 ). Twenty-six full-text reports were excluded: reasons for the exclusions are provided in Appendix S2.

For one study conducted in the Netherlands by Been et al, 54 data were presented using multiple cut-offs to define the pre-and post-pandemic periods, with several different comparisons, making it difficult to select one comparison that aligned well with the other studies; we, therefore, included this study in the systematic review but not in meta-analyses. Khalil et al 9 had overlapping data for stillbirth outcome with another study; however, preterm birth data were not overlapping, so only preterm birth data were used in this review. Study characteristics are reported in Table 1 : eight studies were national in scope, 11 were regional, and 24 were local, including single-center studies. Two studies did not report data settings. One study included in the previous version of this review, Exposed cohort (Pandemic period) Non-exposed cohort (Pre-pandemic period)

Factors adjusted for if any Arnaez Note: A study can be awarded a maximum of one star for each item within the Selection and Outcome categories. A maximum of two stars can be given for comparability.

studied. The duration of the "pandemic period" studied varied from 4 weeks to 12 months, and the duration of the "pre-pandemic period" varied from 2 months to 19 years across studies. The risk of bias scores for the included studies ranged from 5 to 9 (Table 2) .

Twenty-two studies had moderate risk of bias and 23 studies had low risk of bias. Thirty-three studies included pregnant populations from local/regional/national data, which may have included those with COVID-19, whereas eight studies specifically excluded women known to have COVID-19. However, it is difficult to be completely certain as testing on pregnant women was not universally applied in any of the studies. Table 1 ) and pooled analyses did not show any significant differences in the odds of PTB during the pandemic, though the magnitude of the adjusted pooled estimate was the same as the unadjusted pooled estimate (pooled aOR 0.95, 95% CI 0.80-1.13; I 2 = 92%; Figure 3 ). There was no reduction in the unadjusted odds of PTB <34 weeks (Table 3 , Appendix S3), <32 weeks ( 

Twenty-five studies of 498 231 women during the pandemic period and 3 569 667 women in the pre-pandemic period assessed stillbirth.

There was no difference in the odds of stillbirth between the pandemic and pre-pandemic periods (pooled uaOR 1.10, 95% CI 0.98-1.24, Figure 4 ). Subgroup analyses also revealed no difference in stillbirth during the pandemic period compared with the pre-pandemic period in single-center studies and regional/national studies (Figure 4) .

Meta-analysis of adjusted estimates from four studies revealed no difference in stillbirth between pandemic and pre-pandemic periods (aOR 1.06, 95% CI 0.81-1.38; I 2 = 72%; Appendix S8).

Seven studies of 13 871 women during the pandemic period and 49 152 women in the pre-pandemic period reported birthweight. There was a small increase in mean birthweight during the pandemic compared with the pre-pandemic period (pooled mean difference 17 g, 95% CI 7-28g, I 2 = 0%) (Table 3, Appendix S9). There was no difference in the odds of LBW (Table 3 , Appendix S10), VLBW (Table 3 , Appendix S11), or ELBW (Table 3 , Appendix S12).

Six studies of 99 364 neonates during the pandemic period did not

show any difference in neonatal mortality between the pandemic and pre-pandemic periods (pooled uaOR 1.56, 95% CI 0.98-2. 49 , Table 3 , Appendix S13), however, the heterogeneity of results across studies was very high. One national study from nine hospitals in Nepal 8 reported a higher neonatal mortality rate during the pandemic period, which may reflect significant local impact on access to care during the lockdown period.

Four studies reported on maternal mortality. Three reported no significant difference in maternal mortality; however, one study from Mexico 43 reported a significant increase in maternal mortality during the pandemic ( Figure 5 ). The study from Mexico contributed to 98.7% of the weight in this meta-analysis and it also reported that a significant portion of excess mortality was due to respiratory infections including COVID-19.

In meta-regression analyses, duration of the pre-pandemic study period did not emerge as a significant covariate for any outcome (p > 0.05 for all outcomes). We found evidence of publication bias for PTB (Egger's p = 0.002, Appendix S14) but not for stillbirth (Appendix S15), with fewer studies reporting higher rates of PTB during the pandemic period.

In this updated systematic review and meta-analysis, we identified a 5% reduction in the unadjusted odds of PTB in pandemic compared with pre-pandemic time periods, in both spontaneous PTB and medically indicated PTB. However, in subgroup analyses, a significant reduction in PTB was only observed in single-center studies, not in regional or national studies. Although there was no statistically significant difference in the pooled adjusted odds of PTB the magnitude of the pooled estimate was the same as the pooled unadjusted estimate. We identified no difference in any other fetal/ neonatal outcomes, including stillbirths and neonatal mortality, and only a marginal increase of 17 g in mean birthweight during the pandemic period compared with the pre-pandemic period. The increased incidence of maternal mortality noted in our meta-analysis was mostly driven by one study from Mexico 43 that included deaths due to COVID-19; these were the leading cause of maternal mortality during the pandemic period.

This review was designed to evaluate the impact of the COVID-19 pandemic on pregnancy and neonatal outcomes and not to evaluate studies that report only on maternal COVID-19 itself, which has been discussed in other reviews. [56] [57] [58] We specifically excluded studies that only reported outcomes of pregnant individuals infected with COVID-19. We identified conflicting evidence from the included studies based on whether they were single-center or regional/national studies. There could be several reasons for this. In addition to potential referral bias, other potential explanations include variation in sample sizes, outcome definitions, lengths of the pandemic and pre-pandemic periods, differences in timing and enforcement of lockdown orders, failure of some studies to account for natural variation in pregnancy outcomes over time, and dissimilarities among COVID-19 mitigation strategies. 8, 10, 20, 29, 47 Moreover, the study populations were heterogeneous; for example, baseline PTB rates ranged from 4.8% to 16.7% during the pre-pandemic period across the included studies; however, the change in PTB rate between periods was not baseline rate dependent. Although we did not observe any differences in subgroups of PTB using different gestational age cut-offs (ie <34, <32, and <28 weeks), not all studies contributed to these analyses. The effects of lockdowns and mitigation strategies had contrasting effects in high-income versus low-and middle-income countries. 59 Reports from low-resource settings described increased fear and stress among pregnant individuals, reluctance to access in-hospital care during a pandemic, financial or employment issues, childcare or home schooling challenges, maternity staff shortages, reduced access to in-hospital care, and perceived or actual reductions in available obstetric services, resulting in a significant reduction in institutional births. 8, 9, 20, 37, 38 Some reports noted a reduction in PTB and attributed this to a number of social and health behaviors associated with the pandemic, 2,7 including decreased physical and mental stress due to better work-life balance, 6 give birth in hospitals with lower prevalence of COVID-19 or in non-COVID designated hospitals. 33 Future studies are needed to explore these differences.

Although we did not observe an overall change in the odds of stillbirth during the pandemic period, several individual studies, mostly single center in scope, reported increased odds of stillbirth compared with pre-pandemic time periods. The increase in stillbirth reported by these studies was attributed to reduced antenatal surveillance, a reluctance to access in-hospital care due to increased stress and anxiety, 9, 21, 37, 40, 48 or missed appointments due to rapid changes in maternity services during the pandemic. 60 These reasons may also explain an increase in maternal mortality identified in Mexico; 43 however, according to the authors the data from the government website were preliminary in scope and may change as more data are available. This could be a signal to be vigilant in attending the mother-fetus dyad during difficult public health emergency situations.

We did not find any significant differences between the pandemic and pre-pandemic periods for other outcomes, except for a marginal difference in birthweight. As these data came from only five studies, further studies are needed to clarify this association, as a difference of 17 g is unlikely to be of clinical significance. Other factors that could be responsible for the differences between study findings include variations in the etiology of adverse pregnancy outcomes in different countries, 2,20 initiatives by local governments to provide support to those at risk for higher stress, 7 and changes to national legislation on pregnancy termination during the study period potentially influencing the incidences of stillbirth and PTB. 2,7

A key strength of our review was the inclusion of large populations from 18 countries, mainly arising from national or state/provincial data. Most included studies came from registries or similar types of data sets. In addition, we only included studies that reported on temporal changes in outcomes in the overall population, and not data specifically from women affected by COVID-19. However, our study also has limitations. There may be other relevant studies that are not yet published (and so not included) as the pandemic is still ongoing and many countries are facing additional waves of infections and associated public health restrictions. There was clinical and methodological heterogeneity across studies regarding pandemic and pre-pandemic period definitions, population bases (single center/adjacent hospitals vs. regional/national), and choices of statistical methodologies.

To overcome these limitations, we planned a priori to include prepandemic duration in meta-regression analyses, and we conducted post-hoc subgroup analyses on type of studies. We were able to explain statistical heterogeneity to an extent for both of our primary outcomes. Some studies included the entire population of pregnant women, comprising those who did and did not have COVID-19 in their sample. When studies that categorically excluded women with COVID-19 were included in our review, we identified no difference in PTB or stillbirth. Finally, there were insufficient studies to assess some of the pre-specified outcomes, including maternal mortality.

The COVID-19 pandemic has affected many countries with very high case numbers, such as India, Brazil, the UK, and Italy, but large, population-based estimates on pregnancy outcomes from these countries are lacking in this review. National registries from these and other countries would be ideally suited to investigate the impact of the pandemic on perinatal health at a population level. A harmonization of methodological approaches would also facilitate the assessment of the effects of the pandemic period on fetal, neonatal, and maternal outcomes, as high methodological heterogeneity makes direct comparisons challenging. One important point to consider going forward will be that the rates of these outcomes fluctuate with natural variation over time. We hope to capture these fluctuations through further 3-monthly updates of this living systematic review. Future investigations should use approaches that can elucidate whether any fluctuation observed in a particular setting during the pandemic period is outside the range of expected natural variation.

In pooled analyses, we observed reductions in the unadjusted odds of PTB between the pandemic and pre-pandemic periods; in both induced and spontaneous PTB. However, this finding was driven by single-center studies. There was no difference in analyses of adjusted estimates of PTB or within subgroups of PTB. Although we did not observe meaningful differences in other outcomes, including odds of stillbirth, the data were more limited and precluded a robust assessment. Higher maternal mortality reported from Mexico indicates that further studies from low-and middle-income regions highly affected by COVID-19 are needed where drastic changes in the healthcare access, healthcare availability, and personal, social, and environmental factors contributed disproportionately to adverse pregnancy outcomes. As the findings have changed between the review published recently and this current review, there is a need for this type of living systematic review that can be updated regularly.

We 

Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis

An overview of adult health outcomes after preterm birth

Danish premature birth rates during the COVID-19 lockdown

The impact of the Covid-19 pandemic on maternity services: a review of maternal and neonatal outcomes before, during and after the pandemic

Effect of the COVID-19 pandemic response on intrapartum care, stillbirth, and neonatal mortality outcomes in Nepal: a prospective observational study

Change in the incidence of stillbirth and preterm delivery during the COVID-19 pandemic

Preterm birth and stillbirth during the COVID-19 pandemic in Sweden: a nationwide cohort study

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

COVID-19 pandemic and population level pregnancy and neonatal outcomes: a systematic review

COVID-19 pandemic and population-level pregnancy and neonatal outcomes: a living systematic review and meta-analysis

Vital Statistics-Stillbirth Database. Available online at

The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses

Lack of changes in preterm delivery and stillbirths during COVID-19 lockdown in a European region

Decreased incidence of preterm birth during coronavirus disease 2019 pandemic

Are COVID-19 mitigation measures reducing preterm birth rate in China?

Impact of mitigation measures against the COVID 19 pandemic on the perinatal results of the reference maternity hospital in Uruguay

Modest reduction in adverse birth outcomes following the COVID-19 lockdown

Increase of stillbirth and decrease of late preterm infants during the COVID-19 pandemic lockdown

Effects of SARS Cov-2 epidemic on the obstetrical and gynecological emergency service accesses. What happened and what shall we expect now?

Association between the COVID-19 pandemic and the risk for adverse pregnancy outcomes: a cohort study

Changes in obstetric interventions and preterm birth during COVID-19: a nationwide study from Iceland

A decline in planned, but not spontaneous, preterm birth rates in a large Australian tertiary maternity centre during COVID-19 mitigation measures

The effect of the COVID-19 pandemic on maternal health due to delay in seeking health care: experience from a tertiary center

Impact of labor and delivery unit policy modifications on maternal and neonatal outcomes during the coronavirus disease 2019 pandemic

How to prevent inhospital COVID-19 infection and reassure women about the safety of pregnancy: experience from an obstetric center in China

Changes in preterm birth phenotypes and stillbirth at 2 Philadelphia Hospitals during the SARS-CoV-2 pandemic

Association of preterm birth rate with COVID-19 statewide stay-at-home orders in Tennessee

Prevalence of preterm birth rate during COVID-19 lockdown in a Tertiary Care Hospital

Racial/ethnic disparities in very preterm birth and preterm birth before and during the COVID-19 pandemic

Lockdown with a price: the impact of the COVID-19 pandemic on prenatal care and perinatal outcomes in a tertiary care center

Impact of coronavirus diseases-2019 (COVID-19) on utilization and outcome of reproductive, maternal, and newborn health services at governmental health facilities in South West Ethiopia, 2020: comparative cross-sectional study

Preterm delivery and hypertensive disorder of pregnancy were reduced during the COVID-19 pandemic: a single hospital-based study

Pregnancy outcome during the first COVID

Stillbirths and the COVID-19 pandemic: looking beyond SARS-CoV-2 infection

COVID-19 outbreak and decreased hospitalisation of pregnant women in labour

What is driving the decreased incidence of preterm birth during the coronavirus disease 2019 pandemic?

Impact of Wuhan lockdown on the indications of cesarean delivery and newborn weights during the epidemic period of COVID-19

Pregnancy outcomes during the COVID-19 pandemic in Canada

Results of pregnancy control before and during the COVID-19 Pandemic: a comparison of two cohorts

Singleton preterm birth rates for racial and ethnic groups during the coronavirus disease 2019 pandemic in California

Prematurity rates during the coronavirus disease 2019 (COVID-19) pandemic lockdown in

A marked decrease in preterm deliveries during the coronavirus disease 2019 pandemic

Impact of the COVID-19 outbreak on routine obstetrical management

Impact of the COVID-19 pandemic on excess perinatal mortality and morbidity in Israel

Preterm birth and stillbirth rates during the COVID-19 pandemic: a population-based cohort study

Resilience and vulnerability of maternity services in Zimbabwe: a comparative analysis of the effect of Covid-19 and lockdown control measures on maternal and perinatal outcomes at Mpilo Central Hospital

Stillbirths during the COVID-19 pandemic in England

Effect of delayed obstetric labor care during the COVID-19 pandemic on perinatal outcomes

Preterm birth during the coronavirus disease 2019 (COVID-19) pandemic in a large hospital system in the United States

Impact of COVID-19 mitigation measures on the incidence of preterm birth: a national quasi-experimental study

Perinatal outcomes during the COVID-19 pandemic in Ontario, Canada

Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis

Effect of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcome: systematic review

Maternal and neonatal outcomes associated with COVID-19 infection: a systematic review

Effects of the COVID-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis

The impact of the coronavirus (COVID-19) pandemic on maternity care in

Impact of coronavirus outbreak on NO(2) pollution assessed using TROPOMI and OMI observations